AmoyDx(SZ:300685) 智通财经网·2025-10-09 09:20Core Viewpoint - The investment in Sailu Medical by Aide Biological is a strategic move to strengthen its position in the gene testing industry and enhance collaboration within the supply chain [1][2] Group 1: Investment Details - Aide Biological signed a B-round capital increase agreement with Sailu Medical, investing 50 million yuan, with 55,701 yuan allocated to the registered capital and the remainder to capital reserves [1] - Following this investment, Aide Biological holds a 2.3810% stake in Sailu Medical [1] Group 2: Industry Context - Sailu Medical operates in a technology-intensive sector with significant R&D barriers and has developed a self-controlled sequencing technology platform [1] - The company has full R&D and production capabilities for gene sequencing instruments and related consumables, with its SalusPro gene sequencer receiving national Class III medical device registration in January 2025 [1] - The national push for high-end medical equipment to be self-controlled and for import substitution presents strategic growth opportunities for domestic sequencing platform companies with core technologies [1] Group 3: Strategic Implications - The investment is a key strategic deployment for Aide Biological, aligning with the trends in the gene testing industry and enhancing supply chain collaboration [2] - The partnership will leverage Sailu Medical's core advantages in sequencing platforms and Aide Biological's expertise in tumor gene testing, creating a strong complementary effect [2] - This collaboration aims to improve the overall competitiveness of the company in the industry and promote resource integration, fostering a more self-controlled and collaborative industrial ecosystem [2] - The initiative is expected to accelerate innovation and clinical translation of cutting-edge technologies, providing more precise and accessible gene testing solutions for patients [2] - It will further solidify the company's leading position in the field of tumor precision medicine [2]